Cooperative Ovarian Cancer Group
The Cooperative Ovarian Cancer Group (COGI), based at Stanford University, is a consortium of ovarian cancer researchers from leading academic medical centers throughout the United States. This group was formed in 2004 to focus on the development of vaccines and innovative immunotherapies for ovarian cancer.
Since its inception, COGI has supported laboratory and clinical programs to develop immunotherapies for ovarian cancer. We are part of the international consortium of coopertive clinical trials group for gynecologic malignancies, the Gynecologic Cancer Inter Group (GCIG).
Stanford University COGI Contacts
Jonathan Berek, M.D., M.M.S.
Primary Investigator, COGI
Oliver Dorigo, M.D., Ph.D.
Co-Primary Investigator, COGI